Vial – AOD-9604 10mg
-
Name:AOD-9604 (Anti-Obesity Drug Fragment 9604)
-
Sequence:HGH Fragment 176–191
-
Molecular Formula:C₇₈H₁₂₃N₂₃O₂₃S₂
-
Molecular Weight:≈ 1815.10 g/mol
-
CAS Registry Number:221231-10-3
AOD-9604 – COMPREHENSIVE RESEARCH PEPTIDE FOR METABOLIC AND LIPOLYTIC SIGNALING STUDIES
Scientific Overview of AOD-9604
AOD-9604 is a modified peptide fragment derived from the C-terminal region of human growth hormone (HGH), corresponding to amino acids 176–191. It has been extensively investigated in metabolic and adipocyte-related research models for its involvement in lipolytic signaling pathways independent of full HGH endocrine activity.
In experimental research, AOD-9604 has been studied for its effects on:
• Lipolysis and Fat Metabolism – investigation of adipocyte signaling pathways associated with triglyceride breakdown and fatty acid mobilization (Ng et al., 2000)
• Metabolic Regulation and Energy Balance – evaluation of metabolic signaling related to body composition and energy utilization in experimental systems (Heffernan et al., 2001)
• Cartilage and Tissue Research – exploration of chondrocyte activity and tissue-supportive signaling in preclinical studies (Møller et al., 2009)
AOD-9604 serves as a valuable research peptide for investigating metabolic modulation, adipocyte biology, and growth hormone fragment-associated signaling pathways.
